Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources

Baha Abdalhamid, Christopher R. Bilder, Emily L. McCutchen, Steven H. Hinrichs, Scott A. Koepsell, Peter C. Iwen
doi: https://doi.org/10.1101/2020.04.03.20050195
Baha Abdalhamid
aDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
bNebraska Public Health Laboratory, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: babdalhamid@unmc.edu
Christopher R. Bilder
cDepartment of Statistics, University of Nebraska-Lincoln, Lincoln, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily L. McCutchen
aDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
bNebraska Public Health Laboratory, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven H. Hinrichs
aDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott A. Koepsell
aDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Iwen
aDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
bNebraska Public Health Laboratory, University of Nebraska Medical Center, Omaha, NE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To establish the optimal parameters for group testing of pooled specimens for the detection of SARS-CoV-2.

Methods The most efficient pool size was determined to be 5 specimens using a web-based application. From this analysis, 25 experimental pools were created using 50 microliter from one SARS-CoV-2 positive nasopharyngeal specimen mixed with 4 negative patient specimens (50 microliter each) for a total volume of 250 microliter l. Viral RNA was subsequently extracted from each pool and tested using the CDC SARS-CoV-2 RT-PCR assay. Positive pools were consequently split into individual specimens and tested by extraction and PCR. This method was also tested on an unselected group of 60 nasopharyngeal specimens grouped into 12-pools.

Results All 25 pools were positive with Cycle threshold (Ct) values within 0 and 5.03 Ct of the original individual specimens. The analysis of 60 specimens determined that two pools were positive followed by identification of two individual specimens among the 60 tested. This testing was accomplished while using 22 extractions/PCR tests, a savings of 38 reactions.

Conclusions When the incidence rate of SARS-CoV-2 infection is 10% or less, group testing will result in the saving of reagents and personnel time with an overall increase in testing capability of at least 69%.

Key Points SARS CoV-2, COVID-19, Group testing

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Christopher R. Bilder is supported by grant R01 AI121351 from the National Institutes of Health.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is available in the main text, tables and the figure.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
Baha Abdalhamid, Christopher R. Bilder, Emily L. McCutchen, Steven H. Hinrichs, Scott A. Koepsell, Peter C. Iwen
medRxiv 2020.04.03.20050195; doi: https://doi.org/10.1101/2020.04.03.20050195
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
Baha Abdalhamid, Christopher R. Bilder, Emily L. McCutchen, Steven H. Hinrichs, Scott A. Koepsell, Peter C. Iwen
medRxiv 2020.04.03.20050195; doi: https://doi.org/10.1101/2020.04.03.20050195

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1090)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9746)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11618)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (144)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (621)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)